US Patent Issued to UNIVERSITAT DE BARCELONA, UNIVERSITAT POMPEU FABRA, UNIVERSITAT AUTONOMA DE BARCELONA, INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES, FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA on Nov. 4 for "Peptide compounds for reducing side effects of CB1 receptor agonists" (Portuguese, Spanish Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,973, issued on Nov. 4, was assigned to UNIVERSITAT DE BARCELONA (Barcelona, Spain), UNIVERSITAT POMPEU FABRA (Barcelona, Spain), UNIVERSITAT AUTONOMA DE BARCELONA (Barcelona, Spain), INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES (Lisbon, Portugal) and FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA (Lisbon, Portugal).

"Peptide compounds for reducing side effects of CB1 receptor agonists" was invented by Vicent Casado Burillo (Barcelona, Spain), Estefania Moreno Guillen (Barcelona, Spain), Rafael Maldonado Lopez (Barcelona, Spain), David Andreu Martinez (Barcelona, Spain), Maria Gallo (Barcelona, Spain), Leonardo Pardo Carrasco (Barcelona, Spain), Miguel Castanho (Lisbon, Portug...